| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/14/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Sale | Common Stock | 10k | $43.74 | $437.4k | | 08/11/2023 |
| 08/11/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Sale | Common Stock | 10k | $43.71 | $437.1k | | 08/11/2023 |
| 05/05/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 8.1k | $0.00 | $0 | | 05/05/2023 |
| 05/05/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Option to Purchase Common Stock | 11.4k | $31.00 | $352.5k | | 05/05/2023 |
| 01/03/2023 | BELLICUM PHARMACEUTICALS, INC | BLCM | Exercise | Common Stock | 60.4k | $0.00 | $0 | | 01/03/2023 |
| 09/01/2022 | BELLICUM PHARMACEUTICALS, INC | BLCM | Exercise | Common Stock | 35.1k | $0.00 | $0 | | 09/01/2022 |
| 06/16/2022 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 9.5k | $65.06 | $616.1k | | 06/16/2022 |
| 06/07/2022 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Director Stock Options (Right to Buy) | 14.4k | $18.27 | $262.5k | | 06/07/2022 |
| 06/07/2022 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Restricted Stock Units | 8.6k | $0.00 | $0 | | 06/07/2022 |
| 05/05/2022 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Restricted Stock Unit | 6.2k | $0.00 | $0 | | 05/05/2022 |
| 07/01/2021 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Restricted Stock Units | 809 | $0.00 | $0 | | 07/01/2021 |
| 06/22/2021 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Restricted Stock Units | 6.4k | $0.00 | $0 | | 06/22/2021 |
| 06/22/2021 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Director Stock Options (Right to Buy) | 11.6k | $24.88 | $289.5k | | 06/22/2021 |
| 06/17/2021 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 12.5k | $105.08 | $1.3M | | 06/17/2021 |
| 06/15/2021 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 6.5k | $3.05 | $19.8k | | 06/15/2021 |
| 05/05/2021 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Restricted Stock Unit | 5.2k | $0.00 | $0 | | 05/05/2021 |
| 01/04/2021 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Restricted Stock Units | 13.6k | $0.00 | $0 | | 01/04/2021 |
| 11/25/2020 | HALOZYME THERAPEUTICS, INC. | HALO | Sale | Common Stock | 10.4k | $40.41 | $418.8k | | 11/25/2020 |
| 08/13/2020 | HALOZYME THERAPEUTICS, INC. | HALO | Sale | Common Stock | 34.3k | $29.12 | $999.9k | | 08/13/2020 |
| 06/23/2020 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Director Stock Options (Right to Buy) | 5.6k | $52.73 | $294.2k | | 06/23/2020 |
| 06/23/2020 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Restricted Stock Units | 3.1k | $0.00 | $0 | | 06/23/2020 |
| 06/17/2020 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 6k | $111.06 | $666.4k | | 06/17/2020 |
| 06/15/2020 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 6.5k | $8.42 | $54.7k | | 06/15/2020 |
| 05/11/2020 | ACADIA PHARMACEUTICALS INC | ACAD | Exercise | Stock Option (Right to Buy) | 15k | $27.25 | $408.8k | | 05/11/2020 |
| 05/11/2020 | ACADIA PHARMACEUTICALS INC | ACAD | Sale | Common Stock | 26.2k | $51.13 | $1.3M | | 05/11/2020 |
| 05/11/2020 | ACADIA PHARMACEUTICALS INC | ACAD | Exercise | Stock Option (Right to Buy) | 11.2k | $25.24 | $284k | | 05/11/2020 |
| 04/30/2020 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 8.8k | $0.00 | $0 | | 04/30/2020 |
| 09/09/2019 | ACADIA PHARMACEUTICALS INC | ACAD | Sale | Common Stock | 29.6k | $37.79 | $1.1M | | 09/09/2019 |
| 09/09/2019 | ACADIA PHARMACEUTICALS INC | ACAD | Sale | Common Stock | 400 | $38.39 | $15.4k | | 09/09/2019 |
| 09/09/2019 | ACADIA PHARMACEUTICALS INC | ACAD | Exercise | Stock Option (Right to Buy) | 30k | $17.52 | $525.6k | | 09/09/2019 |
| 06/27/2019 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 20k | $100.45 | $2M | | 06/27/2019 |
| 06/26/2019 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Stock Option (Right to Buy) | 22.5k | $25.24 | $567.9k | | 06/26/2019 |
| 06/20/2019 | CHIMERIX INC | CMRX | Grant | Stock Option (Right to Buy) | 21k | $3.37 | $70.8k | | 06/20/2019 |
| 06/13/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 25k | $1.96 | $49k | | 06/13/2019 |
| 05/02/2019 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 12.2k | $0.00 | $0 | | 05/02/2019 |
|